GT
MEDP icon

Greenleaf Trust’s Medpace MEDP Stock Holding History

Greenleaf Trust’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Sell
423
-7
-2% -$3.23K ﹤0.01% 797
2026
Q1 		$206K Sell
430
-1
-0.2% -$512 ﹤0.01% 769
2025
Q4 		$242K Buy
431
+5
+1% +$2.84K ﹤0.01% 728
2025
Q3 		$219K Buy
+426
New +$186K ﹤0.01% 752

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Greenleaf Trust's MEDP Position: Q2 2026 in Review

Greenleaf Trust reduced its Medpace (MEDP) stake by 1.6% in Q2 2026, selling an estimated $3.23K and leaving 423 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #797.

Greenleaf Trust first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $242K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Greenleaf Trust held 423 shares of Medpace worth $224K as of Q2 2026.
  • Greenleaf Trust sold 7 Medpace shares in Q2 2026, an estimated $3.23K.
  • Medpace made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #797 holding.
  • Greenleaf Trust first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Greenleaf Trust's Medpace position peaked at $242K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.